On the afternoon of December 18th, Psychstocks announced BetterLife Pharma (CSE: BETR) at $1.17 per share as its #1 favorite Psychstock for 2021. BETR closed today at its high of day of $2.25 per share. BETR has already gained by 92.3% in only seven trading days!
Numinus Wellness (TSXV: NUMI) gained as much as 9.87% today to hit a new all-time high of $2.45 per share for a gain of 807.41% since we profiled it as our #1 favorite Psychstock at $0.27 per share!
Psychstocks founder Gerard Adams considers RVV and NUMI to be the two highest quality small-cap stocks in the psychedelic space and their incredibly strong performance is proving Gerard right!
Numinus Wellness (TSXV: NUMI) had its biggest up day in history on Wednesday gaining by 34.83% to finish at a new all-time high closing price of $1.20 per share.
Psychedelics industry bellwether Compass Pathways (CMPS) gained $6.62 or 16.21% today to finish at a new all-time high closing price of $47.45 per share! We consider Revive Therapeutics (CSE: RVV) to be the #1 highest quality small-cap psychedelic biotech play.
Following the release of Citron Research’s bullish report on Compass Pathways (CMPS), the stock gained as much as 28.44% to reach a new record high of $47.29 per share, but only finished the day up by 8.91% to $40.10 per share. We believe Andrew Left made a mistake by releasing his report before the open of trading.
We are excited to announce Numinus Wellness (TSXV: NUMI) as our #1 Favorite Pick of 2020